SOURCE Gentris Corporation
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
A mid-stage study of Tranzyme's TZP-102 failed to improve stomach mobility in diabetics.
Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.
The top 10 open-market insider purchases and sales filed at the SEC Wednesday.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.